The New Treatment Landscape of Multiple Myeloma in the Perspective of New Front-line Therapies

The treatment of Multiple Myeloma is changing these years with the approval of new drugs and new combinations of therapies. In this MEDtalk, Claudio Cerchione, M.D., Ph.D., Dirigente Medico Ematologia, IRCCS Istituto Romagnolo per lo Studio dei Tumori “Dino Amadori,” gives his perspective of the treatment now and in the future.